← Dashboard
Nov 06, 2026 01:59 PM ET
Signal
Corporate
Aligos Therapeutics GAAP EPS of -$2.09 beats by $0.19, revenue of $2.83M misses by $2.71M
Aligos EPS beat by $0.19 while revenue missed by $2.71M.
What changed
Aligos EPS beat by $0.19 while revenue missed by $2.71M.
Why it matters
Aligos EPS beat by $0.19 while revenue missed by $2.71M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →